Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...

The latest announcement is out from Village Farms International ( (VFF) ).

As we rev up in 2025, here’s what I see as the main issues/events to watch (and maybe act on) in the industry: For years, “cannabis litigation” didn’t exist because business was conducted in the ...

Recreational cannabis is now legal in 24 states and three more could legalize some form of marijuana sales this year. But ...

Here are our cannabis industry predictions for 2025: The process to reclassify marijuana as a Schedule 3 drug must end ...